In advanced melanoma, Huang et al. demonstrated that patients with higher Ki67 levels of PD-1 + CD8 + T cells in the circulation before immunotherapy displayed worse OS (P = 0.02) than those with lower Ki67 levels [33]. This evidence concerns the gene MKI67 and melanoma.